|国家科技期刊平台
首页|期刊导航|中风与神经疾病杂志|MnSOD、NfL、Lp-PLA2与卒中后认知障碍相关性及联合检测意义

MnSOD、NfL、Lp-PLA2与卒中后认知障碍相关性及联合检测意义OACSTPCD

Correlation between MnSOD,NfL,and Lp-PLA2 and post-stroke cognitive impairment and significance of com-bined measurement

中文摘要英文摘要

目的 探讨锰超氧化物歧化酶(MnSOD)、神经丝轻链蛋白(NfL)、脂蛋白相关磷脂酶A2(Lp-PLA2)与卒中后认知障碍(PSCI)相关性及联合检测意义,以期为临床早期预测评估、制定干预方案提供参考.方法 选取2020年6月―2023年1月郑州市中心医院收治的100例脑卒中患者,根据是否发生PSCI分为PSCI组、无PSCI组,比较两组基线资料、入院时、2周后、4周后MnSOD、NfL、Lp-PLA2,Pearson分析MnSOD、NfL、Lp-PLA2与MoCA评分相关性,多元线性回归分析PSCI的相关影响因素,采用受试者工作特征曲线(ROC)评估入院时、2周后MnSOD、NfL、Lp-PLA2预测PSCI的价值.结果 PSCI组入院时NIHSS评分、脑白质疏松和脑萎缩患者占比高于无PSCI组,MoCA评分低于无PSCI组(P<0.05);两组2周后、4周后MnSOD均高于入院时,NfL、Lp-PLA2均低于入院时,PSCI组2周后、4周后MnSOD低于无PSCI组,NfL、Lp-PLA2高于无PSCI组(P<0.05);入院时、2周后、4周后MnSOD与MoCA评分呈正相关,NfL、Lp-PLA2与MoCA评分呈负相关(P<0.05);入院时NIHSS评分、脑白质疏松、脑萎缩、MnSOD、NfL、Lp-PLA2均与MoCA评分显著相关(P<0.05);入院时、2周后两两联合的AUC大于单独指标,三者联合的AUC>两两联合的AUC,且2周后三者联合的AUC 0.944>入院时三者联合的AUC 0.932,预测敏感度为84.62%,特异度为93.44%.结论 MnSOD、NfL、Lp-PLA2为脑卒中后PSCI的重要因素,能为临床早期评估预测PSCI提供参考依据,以针对性展开后续治疗,改善预后.

Objective To investigate the correlation between manganese superoxide dismutase(MnSOD),neuro-filament light chain(NfL),and lipoprotein-associated phospholipase A2(Lp-PLA2)and post-stroke cognitive impair-ment(PSCI)and the significance of combined measurement,and to provide a reference for early clinical evaluation and formulation of intervention strategies.Methods One hundred patients with stroke admitted to our hospital from June 2020 to January 2023 were divided into PSCI group and non-PSCI group according to whether PSCI occurred.The two groups were compared in terms of baseline data and MnSOD,NfL,and Lp-PLA2 levels at admission and two and four weeks after admission.Pearson analysis was performed to analyze the correlation between MnSOD,NfL,and Lp-PLA2 and the score of Montreal Cognitive Assessment(MoCA).Multiple linear regression analysis was used to analyze the in-fluencing factors for PSCI.Receiver operating characteristic(ROC)curves were plotted to determine the value of Mn-SOD,NfL,and Lp-PLA2 at admission and two weeks after admission in predicting the occurrence of PSCI.Results The PSCI group showed a significantly higher score of the National Institutes of Health Stroke Scale(NIHSS),a significantly higher percentage of white matter osteoporosis,a significantly higher percentage of cerebral at-rophy,and a significantly lower MoCA score than the non-PSCI group at admission(all P<0.05).MnSOD levels were significantly higher two and four weeks after admission than at admission for both groups;NfL and Lp-PLA2 levels were significantly lower two and four weeks after admission than at admission for both groups;two and four weeks after admis-sion,the PSCI group showed significantly lower MnSOD levels and significantly higher NfL and Lp-PLA2 levels than the non-PSCI group(all P<0.05).At admission and two and four weeks after admission,MnSOD levels were positively cor-related with MoCA scores,while NfL and Lp-PLA2 levels were negatively correlated with MoCA scores(all P<0.05).At admission,NIHSS score,white matter osteoporosis,brain atrophy,MnSOD,NfL,and Lp-PLA2 were all signifi-cantly correlated with MoCA score(all P<0.05).At admission and two weeks after admission,the area under the ROC curve(AUC)of the combination of any two indicators was larger than that of any single index,and the AUC of the com-bination of the three indicators was larger than that of the combination of any two indicators.The AUC of the combina-tion of the three indicators was 0.932 at admission,smaller than 0.944 two weeks after admission,with prediction sen-sitivity of 84.62%and specificity of 93.44%.Conclusion MnSOD,NfL,and Lp-PLA2 are important factors affecting the occurrence of PSCI,which can help early clinical evaluation and prediction of PSCI to facilitate subsequent treat-ment and improve patients prognosis.

王跃;李江涛;李佳佳

郑州市中心医院,河南 郑州 450000

临床医学

脑卒中认知障碍锰超氧化物歧化酶神经丝轻链蛋白脂蛋白相关磷脂酶A2相关性

StrokeCognitive impairmentManganese superoxide dismutaseNeurofilament light chainLipoprotein-associated phospholipase A2Correlation

《中风与神经疾病杂志》 2024 (005)

413-419 / 7

河南省医学科技攻关计划联合共建项目(LHGJ20191042)

10.19845/j.cnki.zfysjjbzz.2024.0080

评论